{"id":"https://openalex.org/W2294549295","doi":"https://doi.org/10.1093/jnci/60.5.1029","title":"Comparison of the Antitumor Activity and Toxicity of 2,4-Diamino-5-(1-adamantyl)-6- methylpyrimidine and 2,4-Diamino-5-(1-adamantyl)-6-ethylpyrimidine 2","display_name":"Comparison of the Antitumor Activity and Toxicity of 2,4-Diamino-5-(1-adamantyl)-6- methylpyrimidine and 2,4-Diamino-5-(1-adamantyl)-6-ethylpyrimidine 2","publication_year":1978,"publication_date":"1978-05-01","ids":{"openalex":"https://openalex.org/W2294549295","doi":"https://doi.org/10.1093/jnci/60.5.1029","mag":"2294549295","pmid":"https://pubmed.ncbi.nlm.nih.gov/580441"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/60.5.1029","doi":"https://doi.org/10.1093/jnci/60.5.1029","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/60.5.1029","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI: Journal of the National Cancer Institute","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112030355","display_name":"Sigmund F. Zakrzewski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sigmund F. Zakrzewski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113498789","display_name":"C. Dave","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chandrakant Dave","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Fred Rosen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fred Rosen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":0.5635,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.62682316,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"60","issue":"5","first_page":"1029","last_page":"1033"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.365200012922287,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.365200012922287,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.3353999853134155,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.07890000194311142,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.847000002861023},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6840000152587891},{"id":"https://openalex.org/keywords/walker-256-carcinosarcoma","display_name":"Walker 256 carcinosarcoma","score":0.878000020980835},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.5680000185966492},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8730000257492065},{"id":"https://openalex.org/keywords/bone-marrow-depression","display_name":"bone marrow depression","score":0.7770000100135803},{"id":"https://openalex.org/keywords/pyrimidine-antimetabolites","display_name":"pyrimidine antimetabolites","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.47884297370910645},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4374050199985504},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3714587688446045},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32368484139442444},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.10910317301750183}],"mesh":[{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002279","descriptor_name":"Carcinoma 256, Walker","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007928","descriptor_name":"Lethal Dose 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D012513","descriptor_name":"Sarcoma, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/jnci/60.5.1029","doi":"https://doi.org/10.1093/jnci/60.5.1029","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/60.5.1029","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI: Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:580441","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/580441","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2415790419","https://openalex.org/W2079867668","https://openalex.org/W2029262875","https://openalex.org/W2057762875","https://openalex.org/W2346151530","https://openalex.org/W1998890438","https://openalex.org/W1602459695","https://openalex.org/W2475211596","https://openalex.org/W1503443663","https://openalex.org/W1981794121"],"abstract_inverted_index":{"The":[0,64],"effects":[1],"of":[2,14,28,58,66,94,101],"two":[3],"new":[4],"compounds,":[5],"2,4-diamino-5-(1-adamantyl)-6-methylpyrimidine":[6],"(DAMP)":[7],"and":[8,61,68,88,103,109],"2,4-diamino-5-(1-adamantyl)-6-ethylpyrimidine":[9],"(DAEP),":[10],"on":[11],"the":[12,26,29,56,59,92,98,107],"growth":[13,27,57],"Walker":[15,30,62],"carcinoma":[16],"256":[17],"were":[18],"studied.":[19],"In":[20,51],"Sprague-Dawley":[21],"rats,":[22,102],"both":[23],"compounds":[24],"inhibited":[25,48,55],"tumor,":[31],"which":[32,40],"is":[33,41],"naturally":[34],"resistant":[35],"to":[36,44],"methotrexate.":[37],"Murphy-Sturm":[38,60],"lymphosarcoma,":[39],"extremely":[42],"sensitive":[43],"methotrexate,":[45],"was":[46,70,121],"not":[47,79],"by":[49,72,75,125],"DAMP.":[50],"contrast,":[52],"2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine":[53],"(DDMP)":[54],"tumors.":[63],"toxicity":[65,82],"DAMP":[67,89,104],"DAEP":[69,87],"charaxterized":[71],"convulsions":[73],"followed":[74],"death;":[76],"DDMP":[77,111],"did":[78],"show":[80],"such":[81],"at":[83],"median":[84],"lethal":[85],"doses.":[86],"reversibly":[90],"reduced":[91,113],"number":[93],"polymorphonuclear":[95],"leukocytes":[96],"in":[97],"peripheral":[99],"blood":[100],"also":[105,122],"decreased":[106],"lymphocytes":[108],"platelets;":[110],"markedly":[112,123],"all":[114],"these":[115],"cellular":[116],"elements.":[117],"Consistently,":[118],"bone":[119],"marrow":[120],"depressed":[124],"DDMP.":[126]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}